LncRNA DDX11-AS1 accelerates hepatocellular carcinoma progression via the miR-195-5p/MACC1 pathway.

CONCLUSION: Our data revealed that DDX11-AS1 could act as an oncogenic regulator in HCC, providing a potential therapeutic target for HCC treatment.
PMID: 32961346 [PubMed - as supplied by publisher]

Source: Annals of Hepatology - September 24, 2020 Category: Gastroenterology Tags: Ann Hepatol Source Type: research